Why the study?
Does a turbidimetric immunoassay for HbA1c correlate with a standard HPLC method in diabetic and nondiabetic patients?
Does a turbidimetric immunoassay for HbA1c correlate with a standard HPLC method in diabetic and nondiabetic patients?
The new immunoturbidimetric assay for HbA1c shows good correlation with standard HPLC and is not subject to interference by common hemoglobin variants or labile HbA1c.
Answers are grounded in this paper and cite their sources.
May support alternative HbA1c assay evaluation; leaves open prospective validation across populations before routine use.
Determination of hemoglobin A1c (HbA1c) is one of the most important monitoring procedures for long-term control of diabetes mellitus. Several analytical methods have been developed for the measurement of glycohemoglobin (GHb). Those most frequently used are ion-exchange chromatography for HbA1c and affinity chromatography for total GHb. In this study, a new turbidimetric immunoassay for HbA1c (Boehringer Mannheim, Germany) was evaluated that was performed on a Hitachi 911 clinical chemistry analyzer (Boehringer Mannheim). Good linearity in the range of 5% to 15% HbA1c, within-run and between-run coefficients of variation ranging from 2.4% to 5.9% were obtained. Results of 179 diabetic and nondiabetic patients showed good correlation to those of a routine HPLC method (r = 0.96). In addition, HbA2, HbS, and HbF in samples from nondiabetic patients were not detected by the immunoturbimetric assay and the "labile" HbA1c fraction (Schiff base) did not interfere with the new test.
No takes yet. Share an insight, caveat, or question.
Hamwi et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: